Micron Biomedical raises $33M for needle-free drug delivery tech
January 16, 2025
Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million.
Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million.
GT Medical Technologies announced today that it completed a $37 million first close of a Series D financing round.
CardioFocus today announced the publication of 12-month data from a study of its pulsed field ablation (PFA) system.
Medtronic (NYSE: MDT)+
announced that CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.
An Abbott (NYSE: ABT)+
official said on social media that the company secured a significant Medicare win for its CardioMEMS platform.
Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic platform for urology applications.
TEL AVIV, Israel, Jan. 14, 2025 /PRNewswire/ — BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system.
Robeauté announced today that it raised $28 million to support the development of its neurosurgical microrobot technology.
New discovery makes system monitoring contaminants in drinking water 10 times more sensitive
ENGLEWOOD CLIFFS, N.J., Jan. 13, 2025 /PRNewswire/ — BRAIN.Q, is excited to announce the CE Mark for its BQ 2.0 system, designed to reduce disability following ischemic stroke, the number one cause of disability worldwide.